期刊文献+

全自动酶联免疫吸附法检测血清丙型肝炎抗体精密度评价 被引量:2

Evaluation on precision of serum hepatitis C antibodies determined by automatic ELISA
下载PDF
导出
摘要 目的评价全自动酶联免疫吸附法检测血清丙型肝炎抗体的精密度性能。方法参照美国临床与实验室标准化协会(CLSI)EP5-A2文件,选用2个浓度(高值和低值)的实验样本,每个样本每天批内重复测定2次,每天2批,持续20 d,计算其批内不精密度(CV_(批内))、天间不精密度(CV_(天间))和总不精密度(CV_总)。结果 HCV-Ab低值(L)精密度的CV_(批内)、CV_(天间)、CV_总分别为3.4%、2.8%、5.9%;HCV-Ab高值(H)精密度的CV_(批内)、CV_(天间)、CV_总分别为3.2%、1.9%、3.8%。全自动酶联免疫吸附法检测血清丙型肝炎抗体的CV_(批内)均<1/4EA(5%),CV_(天间)均<1/3EA(6.7%),CV_总均<厂家声明值(15%)。结论全自动酶联免疫吸附法测定血清丙型肝炎抗体精密度符合实验室质量要求。 Objective To evaluate the precision of serum hepatitis C antibodies determined by the automatic enzyme-linked immunosorbent assay(ELISA). Methods According to the EP5-A2 document of American Clinical and Laboratory Standards Institute(CLSI), the experimental samples of two concentrations(high value and low value)were included in the study. Each sample within each batch was measured repeatedly twice daily, 2 batches a day, for continuous 20 days. The within-run imprecision(CV within-run), between-day imprecision(CV between-day) and total imprecision(CV total) were calculated. Results The CV within-run, CV between-day and CV total imprecision of HCV-Ab low value(L) was 3.4%, 2.8% and 5.9%, respectively. The CV within-run, CV between-day and CV total imprecision of HCV-Ab high value(H) was 3.2%, 1.9% and 3.8%, respectively. The automatic ELISA was used to deter-mine serum hepatitis C antibodies and showed that CV within-run imprecision was less than 1/4EA(5%), CV betweenday imprecision was less than 1/3EA(6.7%) and CV total imprecision was less than the total value declared by the manufacturer(15%). Conclusion Using automatic ELISA to determine the precision of serum hepatitis C virus antibodies meets the laboratory quality requirements.
出处 《中国药物与临床》 CAS 2016年第3期305-309,共5页 Chinese Remedies & Clinics
基金 卫生部医药卫生科技发展研究中心资助项目(28-1-45)
关键词 酶联免疫吸附测定 抗体 肝炎 丙型 精密度评价 Enzyme-linked immunosorbent assay Antibodies hepatitis C Precision evaluation
  • 相关文献

参考文献7

  • 1徐洪涛.肝脏免疫学[M].北京:科学技术文献出版社,2010:5.
  • 2Velati C,Romano L,Fomiatti L,et al.Impact of nucleic acid testing for hepatitis B virus,hepatitis C virus,and human immunodeficiency virus on the safety of blood supply in Italy:a 6-years survey[J].Transfusion,2008,48(10):2205-2213.
  • 3Phikulsod S,Oota S,Tirawatnapong T,et al.One-year experience of nucleic acid technology testing for human immunodeficiency virus Type 1,hepatitis C virus and hepatitis B virus in Thai blood donations[J].Transfusion,2009,49(6):1126-1135.
  • 4Hourfar MK,Jork C,Schottstedt V,et al.Experience of German red cross blood services with nucleic acid testing:results of screening more than 30 million blood donations for human immunodeficiency virus-1,hepatitis C virus,and hepatitis B virus[J].Transfusion,2008,48(8):1558-1566.
  • 5Joint Committee for Guides in Metrology.International vocabulary of metrology-basic and general concepts and associated terms(VIM)[S].3rd ed.JCGM 200:2012(E/F)JCGM,2012.
  • 6冯仁丰.再说说精密度[J].检验医学,2014,29(8):787-793. 被引量:16
  • 7熊春林,郭满盈,罗媛烨,杨海燕.丙肝抗体阳性者血清中HCV抗原的检测[J].实验与检验医学,2009,27(3):320-320. 被引量:13

二级参考文献15

  • 1朱阳泉,徐长根,李浩.丙型肝炎病毒及其检测的实验研究进展[J].中国输血杂志,2007,20(5):427-429. 被引量:12
  • 2§ 493. 1253 Standard: establishment and verification of performance specifications [ EB/OL ]. ( 2003-08- 22 ) [ 2014-06-05 ] http ://www. gpo. gov/fdsys/pkg/ CFR-2003 -title42 -vol3/xml/CFR-2003 -title42-vo13 - part493, xml#seqnum493. 1253.
  • 3Joint Committee for Guides in Metrology. International vocabulary of metrology-Basic and general concepts and associated terms (VIM) [ S ], 3rd edition. JCGM 200 : 2012 ( E/F), JCGM, 2012.
  • 4National Committee for Clinical Laboratory Standards. Evaluation of precision performance of quantitative measurement methods [ S ]. EP05-A2, NCCLS,2004.
  • 5Clinical and Laboratory Standard Institute. User verification of performance for precision and trueness[S]. EP15-A2, CLSI, 2005.
  • 6NetrellaMG.实验统计学[M].毛镇道,蒋子刚,译.上海:上海翻译出版公司,1990:351-356.
  • 7National Committee for Clinical Laboratory Standards. Proposed guideline for user evaluation of performance of clinical chemistry devices [ S ]. EPO5-P, NCCLS, 1982.
  • 8National Committee for Clinical Laboratory Standards. Method comparison and bias estimation using patient samples[ S]. EP9-A2, NCCLS, 2002.
  • 9National Committee for Clinical Laboratory Standards. Evaluation of the linearity of quantitative measurement procedures; a statistical approach [ S ]. EP6-A, NCCLS, 2003.
  • 10Clinical and Laboratory Standard Institute. Evaluation of matrix effects[ S]. EP14-A2, CLSI, 2005.

共引文献27

同被引文献13

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部